BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Neodyne Biosciences Announces Positive Interim Randomized Control Trial Results for Embrace™ Advanced Scar Therapy, Demonstrating a Highly Significant Difference in Scar Appearance Compared to Standard-of-Care Treatment

  August 9, 2012

   · 

  4 min read
• Biotech Beach

  Aethlon Medical Announces Expanded Access to Hemopurifier® Therapy For Individuals Infected with Hepatitis C Virus (HCV)

  August 9, 2012

   · 

  6 min read
• BioMidwest

  AspenBio Pharma, Inc. to Provide Shareholders with Business Update

  August 9, 2012

   · 

  3 min read
• Deals

  AstraZeneca PLC Pays $135 Million to Buy Equal Say Over Amylin Pharmaceuticals, Inc. Drugs

  August 9, 2012

   · 

  1 min read
• Biotech Bay

  BioMarin Pharmaceutical Inc. to Present at the Canaccord Genuity Growth Conference

  August 9, 2012

   · 

  1 min read
• Business

  Chembio Diagnostics, Inc. Reports Second Quarter 2012 Financial Results

  August 9, 2012

   · 

  1 min read
• Business

  Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 First Quarter Investor Conference Call on Wednesday, August 15, 2012

  August 9, 2012

   · 

  1 min read
• BioMidwest

  Sagent Pharmaceuticals, Inc. Announces the Launch of Oxaliplatin for Injection, USP

  August 9, 2012

   · 

  1 min read
• Protalix Biotherapeutics, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference

  August 9, 2012

   · 

  1 min read
• Business

  Progenics Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results

  August 9, 2012

   · 

  1 min read